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The esters of o-phthalic acid are employed
extensively in the manufacture of plastics
where they are used to impart flexibility.
Since they are not covalently linked to the
plastic polymer, they can leach from the
matrix, providing opportunity for wide-
spread exposure [see Thomas and Thomas
(1) for review]. The phthalate ester di-n-
butylphthalate (DBP) is used in the manu-
facture of consumer products as diverse as
nail polish, insect repellents, and denture
base material (2-4). DBP has recently been
found to have clinical applications as well,
selectively eliminating tumor cells from
bone marrow (5,6).
DBP has been previously characterized
as a developmental and reproductive toxi-
cant in the rat (7-12). Comparable oral
doses of DBP given to juvenile and adult
male rats produces a testicular lesion char-
acterized by early sloughing of germ cells,
vacuolization of the Sertoli cell cytoplasm,
and testicular atrophy (7,10). It has also
been shown that the testicular toxicity of
phthalates is age dependent, with immature
animals being more sensitive than mature
animals (13,14). However, the reproductive
toxicity following exposure during develop-
ment has not been addressed. Although no
data are available specifically on the trans-
fer of DBP across the placenta, studies
with other phthalate esters show that these
compounds readily cross the placenta of
rats (15-17) and that exposure oflactating
dams to another phthalate, di (2-ethyl-
hexyl) phthalate (DEHP), could lead to
DEHP and mono (2-ethylhexyl) phthalate
(MEHP) exposure in the suckling rat pups.
Because DBP is lipid soluble, as are DEHP
and MEHP, one might predict a certain
degree oflactational transfer ofDBP.
Recently, Jobling et al. (18) reported
that DBP could reduce the binding ofestro-
gen to the estrogen receptor and stimulate
transcriptional activity These authors called
for further in vivodata before any firm con-
clusions as to the estrogenicity of DBP
could be drawn. Review ofarchived chemi-
cal studies generated with the National
Toxicology Program's Reproductive
Assessment by Continuous Breeding
(RACB) protocol revealed an earlier study
that examined the reproductive toxicity of
DBP in Sprague-Dawley rats. Ifthe findings
ofJobling et al. (18) are correct and DBP
can act as an estrogen, then one would
expect to see greater reproductive effects in
second generation animals (195) under the
RACB protocol. This is expected in the
RACB design because the Fo rats are exposed
only as adults, the F1 rats are born to moth-
ers that are treated during gestation and lac-
tation, and the F1 animals themselves are
treated during maturation to sexual maturity
and through mating. The results ofthis DBP
RACB study are presented below; the results
show that structural defects are seen in the
second generation rats that were not found
in the first.
Methods
General. This study was conducted using
the National Toxicology Program's RACB
protocol for which the detailed methods
have been previously described (20,21).
Briefly, the protocol is composed of four
segments, or tasks. Task 1 is a 14-day
range-finding study that is used to set three
dose levels used in Task 2. Task 2 is the 14-
week continuous breeding phase, generat-
ing up to five litters per pair. Task 3 con-
sists of crossover matings between treated
and control Fo animals to determine the
affected sex, and Task 4 assesses the fertility
of the last litter (F1) born during continu-
ous breeding (Task 2).
Chemical. DBP was obtained from
Chem Central via Midwest Research
Institute (Kansas City, MO, Lot/Batch # L-
121 1-83/02). The purity of DBP used in
preparation of the feed formulations was
greater than 99% as determined by gas
chromatography.
Dosedfeedformulations. DBP was
blended into powdered NIH-07 (Zeigler
Bros., Gardeners, PA) feed on a weight-to-
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weight basis. Animals in the control group
received undosed NIH-07. Each dose level
was independently formulated and pre-
pared at least every 3 weeks and stored
frozen. Dosage formulation studies indicat-
ed that DBP blended with feed at a con-
centration of 0.5 mg/g was stable for 3
weeks when sealed at -200C and for 7 days
when open to air and light at room tem-
perature. Thus, dosed feed was stored in
the dark and refrigerated and was changed
offthe cages everyweek.
Animals. VAF Crl:CD BR outbred
Sprague-Dawley albino rats were purchased
from Charles River Breeding Laboratories
(Portage, MI). During quarantine, represen-
tative animals were sacrificed and their sera
evaluated for antibodies against nine rodent
viruses and Mycoplasma pulmonis (Charles
River Professional Services, Wilmington,
MA) All serawere negative forviral antibod-
ies. Animals were quarantined separately for
approximately 3 weeks for Task 1 and 2
weeks forTask 2; rats were 70 days ofage at
the start of both Tasks 1 and 2. Histo-
pathologic evaluations were performed on
representative animals during quarantine to
check for signs ofinfectious disease.
Male and female rats were housed two
per cage by sex during quarantine and the
1-week pre-mating period on SaniChip
bedding (P.J. Murphy Forest Products) in
solid bottom polycarbonate cages with
stainless steel wire-bar lids. Deionized water
and rodent meal feed (NIH-07 diet; Zeigler
Bros.) were provided ad libitum.The rats
were subsequently housed as breeding pairs
or individually at 23 ± 2°C with a 14:10-hr
light:dark cycle. All housing and procedures
were performed in accordance with the
NIEHS guidelines for the humane use of
animals in research.
Studydesign. DBP was administered via
feed to CD Sprague-Dawley rats. In Task 1,
the dose-finding segment ofthe study, doses
of0.0 (control), 0.1, 0.5, 1.0, 1.5, and 2.0%
(w/w) DBP were tested using eight animals
ofeach sex per group. Endpoints for Task 1
were dinical signs of toxicity, body weight,
and food consumption.
In an optimal study, the highest dose
during Task 2 should be set so as not to
depress weight gain by more than 10% or
result in greater than 10% mortality. If a
compound is a reproductive toxicant, the
middle dose should elicit reproductive
effects with little or no systemic toxicity in
evidence, and the lowest dose should pro-
vide a no-effect level. Based on the results
ofthe Task 1 pilot (data not shown), con-
centrations of 0.1, 0.5, and 1.0% DBP in
the feed were selected forTask 2.
Task 2, the continuous breeding phase,
used a control group consisting of 40
male/female breeding pairs and three dose
groups with 20 breeding pairs per group.
The endpoints for Task 2 were clinical
signs oftoxicity, parental body weight and
average consumption offeed during repre-
sentative weeks, fertility (the proportion of
cohabited pairs producing any live pups),
the number oflitters per pair, the number
of live pups per litter, the proportion of
pups born alive, the sex ratio oflive pups,
and the pup body weights immediately
after birth. The pups in the first four litters
were removed after birth, counted,
weighed, sexed, and killed without necrop-
sy. The last litter, born during the holding
period following the continuous breeding
phase, was reared by the dam until weaning
(day 21 after birth); at this time, treatment
ofthe Fl animals was initiated by the same
route and at the same concentrations as
consumed by their parents in Task 2.
These animals were used for assessment of
second generation fertility in Task4.
During Task 2, if an effect on fertility
was detected, a 1-week crossover mating
trial, Task 3, was performed to determine
the affected sex. In this study, this was per-
formed after the last litter of Task 2 was
weaned. The mating trial consisted ofthree
groups of 20 pairs each: control males x
control females, control males x 1%
females, and 1% males x control females.
Endpoints for Task 3 were the same as
Task 2, with the addition of checking for
the presence ofavaginal copulatory plug or
sperm. After the litter in Task 3 had been
delivered, evaluated, and disposed of, the
Fo females were subject to vaginal lavage
for 12 days to evaluate estrous cyclicity; the
control and high dose Fo adults were then
killed by CO2 asphyxiation and subjected
to necropsy. Necropsy endpoints were
organ weights and histopathology, body
weight, epididymal sperm motility (count-
ed visually), sperm morphology, and sperm
count. For histopathological evaluation,
selected organs were examined after fixa-
tion in 10% neutral buffered formalin or
Bouin's fixative (ovaries) and embedded in
glycol methacrylate (testis) or paraffin.
Sections were stained with periodic
acid-Schiff (PAS) and hematoxylin (testis)
or hematoxylin and eosin according to
standard procedures.
Task 4 assessed the growth and fertility
ofFl animals. The last litter from Task 2
was reared, weaned, and held until mating
at postnatal day 88 ± 10. During matura-
tion, siblings were housed by sex at a maxi-
mum oftwo per cage and received the same
chemical treatment as their parents. Upon
reaching sexual maturity, 20 each nonsib-
ling F1 males and females within the same
treatment groups were housed in pairs for 7
days and then housed individually until
delivery of a litter. The endpoints for the
Task 4 mating trial was the same as in Task
2, with the addition of checking for the
presence of a copulatory plug and vaginal
sperm. At the end ofTask 4, F1 animals in
all dose groups were killed by CO2 asphyxi-
ation and subjected to necropsy with the
same endpoints as in theTask 3 necropsy.
Statistics. When data were expressed as
a proportion, such as the fertility, mating,
and pregnancy indices, the Cochran-
Armitage test was used to test for a dose-
related trend (22). Each dose group was
compared to the control group with a X2
test (23). In Task 3, where the animals
were cross-mated and dose groups did not
represent increasing dose levels, a X2 test
for homogeneity was used to test for an
overall difference in fertility among groups
for pairwise comparisons.
The number of litters and the number
oflive pups per litter were computed on a
per-fertile-pair basis and treatment group
means were determined. The proportion of
live pups was defined as the number of
pups born alive divided by the total num-
ber ofpups produced by each pair. The sex
ratio was expressed as the proportion of
male pups born alive divided by the total
number ofpups produced by each pair. In
Task 2, dose group means for these and
other parameters were compared to the
control group with Shirley's test (24,25).
When a trend was present, Jonckheere's
trend test (26) was used, otherwise Dunn's
test (271 was applied. In Task 3, parame-
ters were tested for overall differences using
the Kruskal-Wallis test (28), and multiple
comparisons were made using Dunn's test.
To remove the potential effect of the
number of pups per litter on the average
pup weight, an analysis of covariance
(ANCOVA) was performed (29) using the
average litter size, including live and dead
pups, as the covariate to produce an adjust-
ed live pup weight. Least squares estimates
of dose group means, adjusted for litter
size, were computed and tested for overall
equality using an F-test and pairwise equal-
ity using Dunnett's test (30). To evaluate
potential sex differences, these analyses
were performed on males, females, and
both sexes combined.
Absolute body and organ weights and
organ weights adjusted for body weight
were analyzed by Shirley's or Dunn's test,
while dose-related trends were identified by
Wilcoxon's test in Task 3 or Jonckheere's
test in Task4.
Vaginal cytology data were analyzed
using a multivariate analysis of variance
(ANOVA) (31) to test for the simultaneous
equality ofmeasurement across dose levels.
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Before running the ANOVA, an arcsine
transformation was performed to bring the
data into close conformance with normali-
ty assumptions.
Group means, standard deviations, and
standard errors were calculated for all data
and for each sex. Jonckheere's test was per-
formed to look for increasing or decreasing
trends. Significance among dose groups
was then calculated using Shirley's test ifa
trend was evident or Dunn's test if no
trendwas evident.
Results
Continuous breeding (Task 2).
Representative dosage formulations from
Task 2 were 99-106% of the target con-
centrations. The average daily feed con-
sumption was similar for control and DBP-
dosed animals. During the first 14 days of
Task 2, body weight gain was significantly
lower only in the high-dose females (2%),
compared with a 7% increase for control
females. This resulted in significantly
reduced body weights after each litter and
at necropsy for these high-dose females.
During the course of the Task 2 continu-
ous breeding phase, body weights were
within 10% ofthe controls except for high-
dose females at week 17 (the end ofcohabi-
tation) when they were 11% less than the
controls. Over the duration of continuous
breeding, there were no clinical signs of
toxicity noted during the twice-daily health
surveillance.
Based on body weights and food con-
sumption, the average calculated daily
intakes ofDBP for the 0.1, 0.5, and 1.0%
dose groups were 52, 256, and 509 mg/kg
body weight for males and 80, 385, and
794 mg/kg for females, respectively.
DBP treatment did not affect fertility
or the average number of litters per pair,
but it did dose-dependently reduce the
number of lives pups per litter (Table 1).
In addition, live pup weights (both
absolute and adjusted for litter size) were
significantly decreased in the middle and
high dose groups. The cumulative-days-to-
litter values were similar for control and
treated animals.
Dam weights at delivery were signifi-
cantly decreased at each litter of the high
dose group (by <10%). During nursing of
the final litter, dam weights were signifi-
cantly decreased at postnatal day 21 in the
low dose group (by 7%), at postnatal days
14 and 21 in the middle dose group (by
=6%), and at all time points in the high
dose group (by =10%; data notshown).
Crossover mating (Task 3). Since
adverse effects on reproduction were
observed in Fo rats, the crossover mating
(Task 3) was performed on Fo animals to
Table 1. Reproductive performance offirst generation breeding pairs
Dose groupa
Reproductive parameter 0% 0.1% 0.5% 1% Trend
Average litters per pair 4.8± 0.1 (40) 5.0± 0.1 (20) 4.9± 0.1 (19) 4.9± 0.1 (20) p=0.322
Live pups perlitter 12.9 ± 0.2(40) 11.9 ±0.3(20)* 11.0 ± 0.5(19)* 10.7 ±0.4(20)* p<0.001
Absolute live pupwt(g) 5.96 ±0.06(40) 5.99 ± 0.06(20) 5.74 ±0.07 (19)* 5.38 ±0.10(20)* p<0.001
Adjusted live pupwt(g) 6.04 ±0.06(40) 5.99 ±0.08(20) 5.66 ± 0.08(19)* 5.30 ± 0.08(20)* p<0.001
aData are mean ± SE (number of breeding pairs).
*p< 0.05when dosed groups are compared to controls.
Table2. Mating trial to determine affected sex: fertility and reproductive performance
Treatment groupa
Control male x 1% Male x Control male x Overall
Reproductive parameter control female control female 1% female difference
Mating indexb 16/19(84%) 19/20(95%) 16/19(84%) p= 0.487
Pregnancy indexc 12/18 (67%) 18/20(90%) 15/19(79%) p= 0.212
Fertility indexd 12/15(80%) 18/19 (95%) 15/16(94%) p= 0.303
Live pups per litter 12.7 ± 1.3 (12) 13.4 ± 0.6(18) 12.9 ± 0.7 (15) p= 0.934
Adjusted live pup wt(g) 5.96 ± 0.16(12) 6.16 ± 0.12(18) 5.28 ± 0.14(15)*' p<0.001
aData are mean ± SE (number of breeding pairs).
bNumber offemales with plug/number of cohabiting pairs (% with plug).
cNumber offertile pairs/number of cohabiting pairs(% pregnant).
dNumber offertile pairs/number offemales with plug (% fertile).
*p<0.05when dosed groups are compared to controls.
'Treated groups differ atp<0.05.
determine the affected sex. For Task 3,
control animals were randomly paired with
other control or high dose (1.0%) animals
for 7 days. Among the three groups (con-
trol male x control female, 1% male x con-
trol female, and control male x 1%
female), there was no overall difference
with respect to mating, pregnancy, or fer-
tility indices (Table 2). Live pup weight
adjusted for litter size was significantly
reduced in the control male x 1% female
group. Treated females weighed =11% less
than controls during Task 3 and consumed
=12% less feed. There were no significant
clinical signs oftoxicity noted during Task
3. Although two females died, one in the
control group and the other in the high
dose group, neither of these deaths were
attributed to DBP exposure.
At the end of Task 3 (4 weeks after
cohabitation), male body weights were
unchanged, but high dose females weighed
=14% less than controls. At necropsy of
the controls and high-dose rats, organ-to-
bodyweight ratios for the liver and kidneys
were significantly increased in both sexes in
the high dose group (Table 3). The gross
structure of the reproductive system was
unchanged by DBP consumption, and
sperm studies showed that sperm concen-
tration, motility, percent abnormal forms,
and testicular spermatid head counts were
not affected by 1% DBP consumption.
DBP caused no apparent changes in aver-
age estrous cycle length (control length
4.20 ± 0.07 days; n = 33) or progression
through the stages of the cycle (data not
shown).
Secondgenerationfertility (Task4). The
final Task 2 litters of all dose groups were
reared and exposed to the same concentra-
tions ofDBP between weaning and necrop-
sy as their parents were. Before weaning, Fl
pups were counted and weighed on postna-
tal days 0,4, 7, 14, and 21. Survival was not
affected, but live male and female pup
weights in the 1.0% dose group were signifi-
cantly (10-15%) lower than controls at
postnatal days 0, 14, and 21.
During rearing (at =postnatal day 46),
three F1 males in the high dose group were
found to have small and malformed pre-
puces and/or penises and were without pal-
pable testes. Just prior to mating (postnatal
day =80), one of these males had palpable
testes. No such abnormalities were noted
for the control males.
At 88 (±10) days of age, F1 rats were
cohabited for 1 week. Feed consumption
values during the week of cohabitation
were =12% lower in the 1% DBP dose
group compared to the control group.
Mating, pregnancy, and fertility indices in
the 1.0% group were significantly lower:
only 1 litter was born to 20 breeding pairs
in the high dose group, compared with 19
litters to 20 breeding pairs in the control
group (Table 4). While there was no
change in the numbers oflive pups per lit-
ter, absolute and adjusted live F2 pup
weights were =6-9% lower in all treatment
groups. The average number ofdays to lit-
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ter and average dam weight at deliverywere
not affected by DBP consumption.
At the end of Task 4, all F1 animals
were weighed, killed, and necropsied. The
high dose males and females weighed
=8-14 % less than their controls (Table 5).
Body weights were unchanged in the mid-
dle and lower dose groups. For males, only
the 1% treatment group showed a signifi-
cant increase in liver weight, while kidney
weight was increased at both the middle
and high dose levels. F, females showed no
significant change in liver or kidney
weights. F1 ventral prostate, seminal vesi-
cle/coagulating gland, and right testis
weights all were decreased in the 1.0%
treatment group, while average ovary
weights remained unchanged (Table 5).
Epididymal sperm counts and testicular
spermatid head counts were both reduced
in the high dose group (Table 5).
Epididymal sperm concentration values
(expressed as 1,000 sperm/mg caudal tis-
sue) in high dose rats were 51% those of
control animals. Likewise, both the total
spermatid heads per testis, a measure oftes-
ticular output, and total spermatid head
per gram of testis, a measure of spermato-
genic efficiency, were decreased in 1.0%
DBP treated males.
Histopathologic examination of select-
ed organs was performed on 10 representa-
tive males from the control, 0.5%, and
1.0% groups and is summarized in Table
6. Three males (of 10 total) in the 0.5%
dose group showed degeneration of semi-
niferous tubules, compared with 1 control,
and 8 males in the 1.0% group. In addi-
tion, 7 of the 10 males examined in the
1.0% DBP treatment group demonstrated
apparent interstitial cell hyperplasia.
Finally, half of the rats (5 of 10) observed
in the high dose group had either underde-
veloped or otherwise defective epi-
didymides.
Discussion
The results from the present RACB study
indicate that DBP is a developmental toxi-
cant in that live pup weights (absolute and
adjusted) were significantly decreased in
both the 0.5% and 1.0% dose groups in
Task 2 (Table 1) and in control males x
1.0% dosed females of Task 3 (Table 2).
Decreased fetal weight is considered an
early indicator of developmental toxicity
(32) and has been observed in Wistar rats
treated with 600 mg DBP/kg by gavage on
gestation days 0-21 (33). Similar results
were observed by Reel and Lawton (34) in
an earlier DBP RACB study using Swiss
mice. Although general toxicity of DBP (a
significant increase in liver and kidney
weights in both males and females and
Table 3. Mating trial to determine affected sex: necropsy outcome
Dose group
Organ 0% 1% Difference
Male
Absolute bodywt 683.6 ± 7.6 (40)8 656.8 ± 15.0(20) p<0.154
Adjusted liverwt 37.6 ± 0.63 (40) 43.4 ± 1.1 (20)* p<0.001
Adjusted kidneywt 6.6 ± 0.11 (40) 7.3 ± 0.18 (20)* p=0.004
Female
Absolute bodywt 379.0 ± 9.6(38) 326.4 ± 6.5(19)* p<0.001
Adjusted liverwt 34.0 ± 0.62(38) 38.9 ± 0.69 (19)* p<0.001
Adjusted kidneywt 7.0 ± 0.10(38) 7.6 ± 0.14(19)* p=0.002
aMean ratio (mg/g bodyweight) ± SE (number ofanimals).
*p<0.05when dosed groups are compared to controls (Wilcoxontest).
Table 4. Mating, fertility, and reproductive performance of second generation breeding pairs
Dose groupa
Reproductive parameter 0% 0.1% 0.5% 1% Trend
Mating indexb 20/20(100%) 19/20(95%) 18/20(90%) 6/20(30%)* p<0.001
Pregnancy indexc 19/20(95%) 17/20(85%) 17/20(85%) 1/20(5%)* p<0.001
Fertility indexd 19/20 (95%) 17/19 (89%) 17/18(94%) 1/6(17%)* p<0.001
Live pups per litter 14.0 ± 0.8 (19) 15.5 ± 0.4(17) 12.8 ± 0.8(17) 13.0' p=0.233
Absolute live pup wt(g) 5.97 ± 0.11 (19) 5.60 ± 0.09(17)* 5.60 ± 0.09(17)* 5.00# p=0.020
Adjusted live pup wt(g) 5.98 ± 0.08(19) 5.69± 0.09(17)* 5.50± 0.09(17)* p<0.001
aData are mean ± SE(number of breeding pairs).
bNumber offemales with plug/number of cohabiting pairs (% with plug).
cNumber offertile pairs/number of cohabiting pairs (% pregnant).
dNumber offertile pairs/number offemales with plug (%fertile).
*p<0.05when dosed groups are compared to controls.
'Treated groups differ atp<0.05.
Table 5. Second generation male and female necropsy organ weights
Dose groupa
Organ 0% 0.1% 0.5% 1% Trend
Male
Body(g) 506.0 ± 8.6(20) 508.8 ± 14.2(20) 496.8 ± 11.8(20) 466.7 ± 9.8(20)* p =0.008
Liver 40.7 ± 0.89(20) 38.9 ± 0.68(20) 40.2 ± 0.95(20) 47.4± 0.73(20)* p<0.001
Kidneys 7.7± 0.11 (20) 7.9±0.14(20) 8.2± 0.10(20)* 8.2± 0.14(20)* p =0.006
Prostate 1.7 ± 0.07(20) 1.6 ± 0.13(20) 1.5 ± 0.07(20) 1.3 ± 0.11 (20)* p =0.022
Seminal vesicles 5.0 ± 0.18(20) 5.1 ± 0.23(20) 5.0 ± 0.17(20) 3.9 ± 0.30(20)* p =0.003
Righttestis (mg)b 1774.6 ± 67.0(20) 1767.4 ±47.8(20) 1810.7 ± 105(20) 1087.9 ± 125(20)* p =0.008
Epididymal sperm parmeters
Number 574.9 ±37.6(19) 575.8 ± 22.2(20) 547.5 ± 36.9(19) 295.1 ± 84.5(18) p =0.017
Percentmotilec 71.0 ± 1.6(19) 72.0 ± 2.0(20) 69.8 ± 1.5(20) 72.4± 3.2(9) p =0.770
Percentabnormald 1.0 ± 0.21 (18) 0.97 ± 0.12(20) 1.0 ± 0.14(19) 0.94± 0.12(7) p =0.470
Total spermatid heads
pertestise(x 107) 14.52 ± 0.95(20) 16.84 ± 0.61 (20) 15.26 ± 0.99(20) 6.69± 1.73(20)'
Total spermatid heads
pergtestisf(x 107) 8.29 ± 0.58(20) 9.64 ± 0.41 (20) 8.29 ± 0.54(20) 4.37 ± 0.98(20) -
Female
Body(g) 323.0 ± 5.1 (20) 311.6 ± 9.3(20) 318.6 ± 8.6(20) 281.2± 8.6(20)* p<0.001
Liver 37.0 ± 0.82(20) 36.3 ± 0.77(20) 37.4± 0.96(20) 37.9 ± 0.62(20) p =0.275
Kidneys 7.4 ± 0.11 (20) 7.7 ± 0.14(20) 7.8 ± 0.26(20) 7.8± 0.14(20) p =0.128
Rightovary 0.16± 0.01 (20) 0.19± 0.01 (20) 0.18± 0.01 (20) 0.15± 0.01(19) p =0.250
aMean ratio (mg/g bodyweight) ± SE (number ofanimals).
bNotadjusted for bodyweight.
cDose group means and SEs are computed onlyfrom sampleswith atleast20 sperm.
dDose group means and SEs are computed onlyfrom sampleswith atleast 100 sperm.
eX(10,000)Y, (X, average number ofspermatid heads pertertiarysquare; Y, dilution factor).
'Total spermatid heads pertestis/testicularweight in grams.
'Significantly different(p<0.05) from the control group.
*p<0.05when dosed groups are compared to controls.
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Table 6. Summary of incidence of histopathologic
lesions (Task4)
Treatment group
Control 0.5% 1.0%
Liver(total examined) (10) (10) (10)
Hepatocellular degeneration 3a 1
Focal hepatitis 6 1 4
Testis (total examined) (1O)b (10) (10)
Degeneration of 1 3 8
seminiferoustubules
Interstitial cell hyperplasia 1 1 7
Granuloma 1
Epididymis (total examined) (10) (10) (10)
Degeneration of 1 2 1
epithelial cells
Interstitial epididymitis 1 1 1
Focal granuloma 1
Underdeveloped epididymis - 5
Presence offluid/ 1 1 2
degenerated cells
Apparentsperm content 1 1 3
reduction
Seminal vesicles (10) (10) (10)
(total examined)
Vesticulitis - 1
Inspissated secretion 1
aNumber ofanimals exhibiting lesion.
bOne animal had variable loss of spermatogonia,
spermatocytes, and spermatids and had an apparent
increased numberofSertoli andinterstitial cells.
reduction in body weight in females) was
observed in the 1.0% DBP group, there
was no difference in the body weights
between the control and 0.5% dose groups.
This shows that pup weight was reduced in
the absence ofa change in maternal weight
at 0.5% DBP.
In the litters produced by the F1 adults
(Task 4), decreased live pup weights
(absolute and adjusted) were observed in all
the dose groups (including the 0.1% dose
group). This was seen in the absence of
obvious general toxicity (Table 5). These
results suggest that the animals exposed
during development were much more sen-
sitive to the developmental toxicity ofDBP
than were animals exposed only as adults.
Furthermore, severe structural defects in
the male reproductive system were
observed in the 0.5% and 1.0% dose
groups (results in Task 4 andTable 6). The
structural defects included small and mal-
formed prepuces and/or penises, underde-
veloped or otherwise defective epi-
didymides, and degenerate seminiferous
tubules. From these data alone, we cannot
deduce whether the effects represent devel-
opmental toxicity alone, if developmental
exposure renders the animals more suscep-
tible to the adverse effects of DBP during
adult exposure, or both, but if DBP is an
estrogenic compound (18), the former may
be more likely.
The statistically significant decreases in
the number of live pups per litter seen in
all Fo dose groups during continuous
breeding (Task 2, Table 2) were not seen
in the Task 3 crossover or in the second
generation (Tables 2 and 4, respectively),
despite being ofequivalent absolute magni-
tude (i.e., =two pups per litter). Earlier
analyses (35) suggest that this is due in part
to the differences in statistical sensitivity: in
Task 2, up to five litters were generated,
while Tasks 3 and 4 generated only one lit-
ter. The multiple litters in Task 2 yield a
test that is statistically much more powerful
than the single litters of the Task 3 or 4
mating trials. Based on this, one might pre-
dict that the nonsignificant difference
between the controls and middle dose ani-
mals in Task 4 (14 vs. 12.8) would become
statistically significant if five litters were
produced.
While the reproductive toxicity ofDBP
was relatively mild in the Fo rats (Table 1,
Table 2), the reproductive functions ofF1
rats were severely damaged. First, all the
indices (mating, pregnancy, and fertility
index) in F1 1.0% dose group were signifi-
cantly reduced because only one litter of
live youngwas delivered (Table 4). Second,
while the weight of the right ovary ofFI
females in all the dose groups remained
normal, the weights of ventral prostate,
seminal vesicles/coagulating gland, and
right testis in F1 males of the 1.0% dose
group were markedly reduced. This may
indicate that the F1 males are more sensi-
tive to DBP than F1 females, although the
ovary is notoriously insensitive as an index
of female reproductive toxicity (35,36).
Third, histologic examination ofthe repro-
ductive systems ofF1 males showed degen-
eration in seminiferous tubules together
with significantly fewer spermatids in testes
(Table 5, 6). While the numbers of epi-
didymal sperm were reduced at the high
dose, morphology and visually estimated
motility were normal in all groups; the
high dose animals were making fewer
sperm, although these sperm appeared nor-
mal. In contrast to the males, female rats in
both the Fo and F1 generations seemed to
be relatively resistant to the reproductive
toxicity ofDBP in terms ofnumbers oflive
young and necropsy endpoints. But in the
Fo generation, females appeared to be more
sensitive to the systemic toxicity of DBP
because the body weight ofFo females in
the 1.0% dose group was significantly
decreased while the males at that concen-
tration showed no detectable change.
Consistent with previous reports on
other phthalates (13), the present data
indicate that effects of DBP exposure are
greater in animals exposed from conception
than those exposed as adults only. Because
the F1 rats were possibly exposed during
gestation and throughout nursing and were
dosed during maturation until and through
mating, we cannot specify which period of
development (e.g., which developmental
trimester, nursing, puberty, etc.) is more
sensitive to the effects of DBP. However,
the male reproductive structural defects
suggest that the period of organogenesis
and perhaps hormonal imprinting for these
tissues, in the prenatal and perinatal peri-
ods, is the most critical time. The mecha-
nisms underlying this developmental toxic-
ity are still unknown. In the past, most of
the toxicity studies on phthalates have
focused on their adverse effects on dosed
juvenile and adult animals, rather than on
pups of dosed dams. Nevertheless, these
early studies have led to the widespread
view that phthalates affect the testis pri-
marily at the Sertoli cells (14,37,38).
Indeed, in neonatal rat testes, significant
decreases in testis weights and Sertoli cell
numbers after five daily oral doses of 1000
mg/kg DEHP have been reported by
Dostal et al. (39).
Jobling et al. (18) found that DBP
interacted weakly with the estrogen recep-
tor in a variety of constructs. If DBP
demonstrated such an interaction in vivo,
one would expect to find altered reproduc-
tive development (19). The present study
found such alterations: degenerate seminif-
erous tubules with decreased sperm counts,
apparent interstitial cell hyperplasia, and
structural defects in epididymides and
penises of 1.0% DBP-treated F1 rats when
they reached maturity. These mirror simi-
lar effects seen in rats and mice exposed
perinatally to the strong estrogen agonist
diethylstilbestrol (DES) (40,41) and are
consistent with the possibility that the
effects seen in the present study were medi-
ated through an interaction with the estro-
gen receptor system. Interestingly, there are
also reports showing that some phthalates
have hormone-disrupting effects in male
adult rats (42-44).
In conclusion, the results from the pre-
sent RACB studyindicate that the develop-
mental and reproductive toxicities of DBP
are more prominent in animals exposed
during development and maturation than
in animals exposed as adults only. This is
prompting an investigation ofthe period of
sensitivity for more ofthe phthalates.
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